C12N 2795/12011
Dsrna bacteriophages
Official title: dsRNA Bacteriophages
C12N2795/12011 (Dsrna bacteriophages) appears on 12 US grants and 14 published applications in this corpus.
Search patents in C12N- Granted patents
- 12
- Published applications
- 14
- Assignees
- 13
- Inventors
- 52
- Latest grant
- 24 Aug 2021
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1996 | 1 | 0 |
| 1997 | 0 | 0 |
| 1998 | 0 | 0 |
| 1999 | 0 | 0 |
| 2000 | 1 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 0 |
| 2004 | 0 | 1 |
| 2005 | 0 | 0 |
| 2006 | 1 | 2 |
| 2007 | 0 | 0 |
| 2008 | 1 | 0 |
| 2009 | 1 | 1 |
| 2010 | 1 | 0 |
| 2011 | 0 | 3 |
| 2012 | 0 | 0 |
| 2013 | 0 | 0 |
| 2014 | 1 | 1 |
| 2015 | 0 | 1 |
| 2016 | 1 | 1 |
| 2017 | 0 | 0 |
| 2018 | 0 | 0 |
| 2019 | 1 | 1 |
| 2020 | 1 | 0 |
| 2021 | 2 | 1 |
| 2022 | 0 | 0 |
| 2023 | 0 | 2 |
By publication year. Applications have been published since 2001.
Subgroups
Granted patents
- C12N 2795/12041Use of virus, viral particle or viral elements as a vectorIndexing code5
- C12N 2795/12031Uses of virus other than therapeutic or vaccineIndexing code3
- C12N 2795/12022New viral proteins or individual genes, new structural or functional aspects ofIndexing code2
- C12N 2795/12032Use of virus as therapeutic agent, other than vaccineIndexing code2
- C12N 2795/12021Viruses as suchIndexing code1
- C12N 2795/12061Methods of inactivation or attenuationIndexing code1
- C12N 2795/12023Virus like particles [vlp]Indexing code0
- C12N 2795/12033Use of viral protein as therapeutic agent other than vaccineIndexing code0
Recent patents
- Virulent Pseudomonas fluorescens phage ΦPf1901, and phage ΦPf901 preparation and application thereof24 Aug 2021US 11,098,285 B2Bohai University
- Bacteriophage and methods of making and using15 Jun 2021US 11,034,936 B2Altria Client Services LLC
- Bacteriophages expressing antimicrobial peptides and uses thereof9 Jun 2020US 10,676,721 B2Massachusetts Institute of Technology
- Bacteriophage and methods of making and using13 Aug 2019US 10,377,992 B2Altria Client Services LLC
- Bacteriophage and methods of making and using6 Sep 2016US 9,433,239 B2Altria Client Services LLC
- Fusobacterium bacteriophage and uses thereof7 Dec 2023US 2023/0390349 A1Biomx Ltd.
- Bacteriophage compositions and uses thereof9 Mar 2023US 2023/0074892 A1Yale University
- Virulent pseudomonas fluorescens phage pf1901, and phage pf1901 preparation and application thereof28 Jan 2021US 2021/0024899 A1Bohai University
- Bacteriophage and Methods of Making and Using4 Jul 2019US 2019/0203185 A1Altria Client Services LLC
- Bacteriophage and methods of making and using22 Dec 2016US 2016/0369245 A1Altria Client Services LLC
Most cited
By later US patents
- Inactivation of extracellular enveloped viruses in blood and blood components by phenthiazin-5-ium dyes plus light51US 5,545,516 AAmerican National Red Cross · 1996
- Recombinant double-stranded RNA phages and uses thereof5US 7,407,790 B2University of Maryland Biotechnology Institute · 2008
- Recombinant double-stranded RNA phage, and use of the same4US 7,018,835 B22006
- Recombinant double-stranded RNA phage, and use of the same3US 7,569,219 B2University of Maryland Biotechnology Institute · 2009
- Recombinant double stranded RNA nucleocapsid and use of the same3US 7,850,958 B2University of Maryland Biotechnology Institute · 2010